US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 20.470
  • -2.000-8.90%
Close Dec 12 16:00 ET
  • 20.470
  • 0.0000.00%
Post 20:01 ET
307.08MMarket Cap-4.31P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
-24.25%-11.98M
-41.86%-13.27M
27.28%-10.34M
-36.17%-45.86M
13.29%-12.65M
Net income from continuing operations
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
Operating gains losses
----
----
----
107.99%575K
--0
--0
--0
109.50%575K
-339.92%-7.2M
-200.00%-150K
Depreciation and amortization
96.01%541K
8.73%299K
5.11%288K
13.64%1.11M
3.66%283K
2.99%276K
26.15%275K
26.85%274K
158.62%975K
40.72%273K
Other non cash items
146.05%105K
137.74%120K
-84.24%136K
107.44%401K
833.33%84K
31.33%-228K
40.00%-318K
119.02%863K
40.69%-5.39M
100.30%9K
Change In working capital
-52.89%1.94M
-31.37%1M
-480.66%-3.6M
886.29%5.1M
-21.52%-1.42M
129.53%4.12M
28.07%1.46M
139.20%946K
-140.04%-649K
59.44%-1.17M
-Change in receivables
--0
--0
--0
200.00%663K
--0
--0
--0
--663K
-210.50%-663K
---663K
-Change in prepaid assets
-131.55%-443K
-107.93%-28K
175.17%218K
145.83%767K
48.42%-700K
38.87%1.4M
-61.92%353K
-7.81%-290K
114.10%312K
29.54%-1.36M
-Change in payables and accrued expense
-14.98%2.48M
-4.46%1.01M
-560.71%-3.51M
495.59%5.2M
223.10%469K
205.87%2.92M
488.83%1.05M
136.82%761K
-133.74%-1.32M
3.54%-381K
-Change in other current assets
341.18%150K
-7.14%260K
-335.29%-80K
-412.28%-584K
-331.48%-932K
0.00%34K
723.53%280K
0.00%34K
67.15%-114K
37.75%-216K
-Change in other current liabilities
-4.66%-247K
-4.41%-237K
-4.95%-233K
-183.55%-945K
-117.98%-260K
-15.69%-236K
---227K
-100.00%-222K
456.78%1.13M
760.27%1.45M
Cash from discontinued investing activities
Operating cash flow
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
-24.25%-11.98M
-41.86%-13.27M
27.28%-10.34M
-36.17%-45.86M
13.29%-12.65M
Investing cash flow
Cash flow from continuing investing activities
-274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
0
95.47%-11K
10.34%-26K
76.28%-576K
88.47%-82K
Net PPE purchase and sale
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
--0
95.47%-11K
10.34%-26K
76.28%-576K
88.47%-82K
Cash from discontinued investing activities
Investing cash flow
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
--0
95.47%-11K
10.34%-26K
76.28%-576K
88.47%-82K
Financing cash flow
Cash flow from continuing financing activities
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
3,500.00%36K
-2,446.15%-305K
780,753.85%101.51M
-99.95%55K
103.08%28K
Net common stock issuance
--0
--0
-53.49%47.2M
--101.48M
--0
--0
--0
--101.48M
--0
--0
Proceeds from stock option exercised by employees
-75.00%9K
-49.16%181K
381.25%154K
721.82%452K
0.00%28K
3,500.00%36K
2,638.46%356K
146.15%32K
-76.69%55K
-17.65%28K
Net other financing activities
----
----
----
---960K
---299K
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
3,500.00%36K
-2,446.15%-305K
780,753.85%101.51M
-99.95%55K
103.08%28K
Net cash flow
Beginning cash position
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
-54.53%38.67M
103.02%104.28M
89.82%116.23M
83.31%129.82M
-54.53%38.67M
321.37%85.05M
-49.27%51.37M
Current changes in cash
-19.86%-14.32M
14.22%-11.66M
-65.35%31.59M
204.87%48.64M
-33.70%-16.98M
-21.10%-11.95M
-41.75%-13.59M
740.59%91.15M
-171.50%-46.38M
21.62%-12.7M
End cash Position
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
125.78%87.3M
103.02%104.28M
89.82%116.23M
83.31%129.82M
-54.53%38.67M
-54.53%38.67M
Free cash flow
-19.57%-14.33M
10.89%-11.84M
-52.12%-15.76M
-12.71%-52.33M
-31.28%-16.71M
-21.45%-11.98M
-38.38%-13.28M
27.25%-10.36M
-28.60%-46.43M
16.78%-12.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M-24.25%-11.98M-41.86%-13.27M27.28%-10.34M-36.17%-45.86M13.29%-12.65M
Net income from continuing operations -6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M
Operating gains losses ------------107.99%575K--0--0--0109.50%575K-339.92%-7.2M-200.00%-150K
Depreciation and amortization 96.01%541K8.73%299K5.11%288K13.64%1.11M3.66%283K2.99%276K26.15%275K26.85%274K158.62%975K40.72%273K
Other non cash items 146.05%105K137.74%120K-84.24%136K107.44%401K833.33%84K31.33%-228K40.00%-318K119.02%863K40.69%-5.39M100.30%9K
Change In working capital -52.89%1.94M-31.37%1M-480.66%-3.6M886.29%5.1M-21.52%-1.42M129.53%4.12M28.07%1.46M139.20%946K-140.04%-649K59.44%-1.17M
-Change in receivables --0--0--0200.00%663K--0--0--0--663K-210.50%-663K---663K
-Change in prepaid assets -131.55%-443K-107.93%-28K175.17%218K145.83%767K48.42%-700K38.87%1.4M-61.92%353K-7.81%-290K114.10%312K29.54%-1.36M
-Change in payables and accrued expense -14.98%2.48M-4.46%1.01M-560.71%-3.51M495.59%5.2M223.10%469K205.87%2.92M488.83%1.05M136.82%761K-133.74%-1.32M3.54%-381K
-Change in other current assets 341.18%150K-7.14%260K-335.29%-80K-412.28%-584K-331.48%-932K0.00%34K723.53%280K0.00%34K67.15%-114K37.75%-216K
-Change in other current liabilities -4.66%-247K-4.41%-237K-4.95%-233K-183.55%-945K-117.98%-260K-15.69%-236K---227K-100.00%-222K456.78%1.13M760.27%1.45M
Cash from discontinued investing activities
Operating cash flow -17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M-24.25%-11.98M-41.86%-13.27M27.28%-10.34M-36.17%-45.86M13.29%-12.65M
Investing cash flow
Cash flow from continuing investing activities -274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K095.47%-11K10.34%-26K76.28%-576K88.47%-82K
Net PPE purchase and sale ---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K--095.47%-11K10.34%-26K76.28%-576K88.47%-82K
Cash from discontinued investing activities
Investing cash flow ---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K--095.47%-11K10.34%-26K76.28%-576K88.47%-82K
Financing cash flow
Cash flow from continuing financing activities -75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K3,500.00%36K-2,446.15%-305K780,753.85%101.51M-99.95%55K103.08%28K
Net common stock issuance --0--0-53.49%47.2M--101.48M--0--0--0--101.48M--0--0
Proceeds from stock option exercised by employees -75.00%9K-49.16%181K381.25%154K721.82%452K0.00%28K3,500.00%36K2,638.46%356K146.15%32K-76.69%55K-17.65%28K
Net other financing activities ---------------960K---299K--0----------------
Cash from discontinued financing activities
Financing cash flow -75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K3,500.00%36K-2,446.15%-305K780,753.85%101.51M-99.95%55K103.08%28K
Net cash flow
Beginning cash position -7.74%107.24M-8.42%118.89M125.78%87.3M-54.53%38.67M103.02%104.28M89.82%116.23M83.31%129.82M-54.53%38.67M321.37%85.05M-49.27%51.37M
Current changes in cash -19.86%-14.32M14.22%-11.66M-65.35%31.59M204.87%48.64M-33.70%-16.98M-21.10%-11.95M-41.75%-13.59M740.59%91.15M-171.50%-46.38M21.62%-12.7M
End cash Position -10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M125.78%87.3M103.02%104.28M89.82%116.23M83.31%129.82M-54.53%38.67M-54.53%38.67M
Free cash flow -19.57%-14.33M10.89%-11.84M-52.12%-15.76M-12.71%-52.33M-31.28%-16.71M-21.45%-11.98M-38.38%-13.28M27.25%-10.36M-28.60%-46.43M16.78%-12.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.90%
Apple
AAPL
+0.60%
Cisco
CSCO
+0.44%
Advanced Micro Devices
AMD
+0.35%
Alibaba
BABA
+0.28%

Unlock the Full List